✦ LIBER ✦
Neoadjuvant systemic therapy for ER+ breast cancer: Is it safe to assess therapy responses based on immunohistochemical assessment of molecular sub-typing?
✍ Scribed by Hussain, Tasadooq; Grover, Kartikaye; Mahapatra, Tapan; McManus, Penelope; Dhadda, Amandeep; Kneeshaw, Peter
- Book ID
- 122244183
- Publisher
- Elsevier Science
- Year
- 2013
- Tongue
- English
- Weight
- 50 KB
- Volume
- 11
- Category
- Article
- ISSN
- 1743-9191
No coin nor oath required. For personal study only.